Amantadine as N-methyl-d-aspartic acid receptor antagonist: new possibilities for therapeutic applications?

This publication has 10 references indexed in Scilit:

• Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study
  European Journal of Pharmacology: Molecular Pharmacology, 1991
• NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats
  Annals of Neurology, 1990
• Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
  Science, 1990
• Potential Therapeutic Uses of N-Methyl-D-Aspartate Antagonists in Cerebral Ischemia
  Clinical Neuropharmacology, 1990
• The quinolinic acid hypothesis in Huntington's chorea
  Journal of the Neurological Sciences, 1990
• Stimulation of D‐2 Dopamine Receptors Decreases the Evoked In Vitro Release of [³H] Acetylcholine from Rat Neostriatum: Role of K⁺ and Ca²⁺
  Journal of Neurochemistry, 1989
• N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids
  Nature, 1982
• Effect of amantadine on drug‐induced parkisonism: relationship between plasma levels and effect.
  British Journal of Clinical Pharmacology, 1976
• Dopamine: Release from the Brain in vivo by Amantadine
  Science, 1971
• Amantadine in the Treatment of Parkinson's Disease
  JAMA, 1969